Publication: Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
dc.contributor.author | Sánchez-Hernández, Sabina | |
dc.contributor.author | Aguilar-González, Araceli | |
dc.contributor.author | Guijarro-Albaladejo, Beatriz | |
dc.contributor.author | Maldonado-Pérez, Noelia | |
dc.contributor.author | Ramos-Hernández, Iris | |
dc.contributor.author | Cortijo-Gutiérrez, Marina | |
dc.contributor.author | Sánchez Martín, Rosario María | |
dc.contributor.author | Benabdellah, Karim | |
dc.contributor.author | Martin, Francisco | |
dc.contributor.authoraffiliation | [Sánchez-Hernández,S; Aguilar-González,A; Guijarro-Albaladejo,B; Maldonado-Pérez,N; Ramos-Hernández,I; Cortijo-Gutiérrez,M; Benabdellah,K; Martin,F] Genomic Medicine Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain. [Aguilar-González,A; Sánchez Martín,RM] Department of Medicinal & Organic Chemistry and Excellence Research Unit of “Chemistry Applied to Biomedicine and the Environment”, Faculty of Pharmacy, University of Granada, Granada, Spain. | |
dc.contributor.funder | This study was funded by the Spanish ISCIII Health Research Fund and the European Regional Development Fund (FEDER) through research grants PI15/02015, PI18/00337 (F.M.) and PI18/00330 (K.B.) The CECEyU and CSyF of the Junta de Andalucía EDER/European Cohesion Fund (FSE) for Andalusia provided the following research grants: 2016000073391-TRA, 2016000073332-TRA, PI-57069, CARTPI-0001-201 and PAIDI-Bio326 (F.M.) and PI-0014-2016 (K.B). K.B. held a Nicolas Monardes regional Ministry of Health contract (0006/2018). S.S.H is funded thanks to Fundación Poco Frecuente donations. A.A.-G. and N.M.-P. are funded by Spanish Ministry of Science and Innovation (SMSI) through fellowships FPU17/04327 and FPU17/02268 respectively. I.R.H is funded by the ISCIII through a PFIS fellowship (FI19/00163). M.C.-G. is funded by (SMSI) through fellowship GJ (PEJ-2018-001760-A). | |
dc.date.accessioned | 2022-08-04T10:10:25Z | |
dc.date.available | 2022-08-04T10:10:25Z | |
dc.date.issued | 2020-06-18 | |
dc.description.abstract | In spite of the enormous potential of CRISPR/Cas in basic and applied science, the levels of undesired genomic modifications cells still remain mostly unknown and controversial. Nowadays, the efficiency and specificity of the cuts generated by CRISPR/Cas is the main concern. However, there are also other potential drawbacks when DNA donors are used for gene repair or gene knock-ins. These GE strategies should take into account not only the specificity of the nucleases, but also the fidelity of the DNA donor to carry out their function. The current methods to quantify the fidelity of DNA donor are costly and lack sensitivity to detect illegitimate DNA donor integrations. In this work, we have engineered two reporter cell lines (K562_SEWAS84 and K562GWP) that efficiently quantify both the on-target and the illegitimate DNA donor integrations in a WAS-locus targeting setting. K562_SEWAS84 cells allow the detection of both HDR-and HITI-based donor integration, while K562GWP cells only report HDR-based GE. To the best of our knowledge, these are the first reporter systems that allow the use of gRNAs targeting a relevant locus to measure efficacy and specificity of DNA donor-based GE strategies. By using these models, we have found that the specificity of HDR is independent of the delivery method and that the insertion of the target sequence into the DNA donor enhances efficiency but do not affect specificity. Finally, we have also shown that the higher the number of the target sites is, the higher the specificity and efficacy of GE will be. | es_ES |
dc.description.version | Yes | es_ES |
dc.identifier.citation | Sánchez-Hernández S, Aguilar-González A, Guijarro-Albaladejo B, Maldonado-Pérez N, Ramos-Hernández I, Cortijo-Gutiérrez M, et al.Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System. Cells. 2020 Jun 18;9(6):1492 | es_ES |
dc.identifier.doi | 10.3390/cells9061492 | es_ES |
dc.identifier.essn | 2073-4409 | |
dc.identifier.pmc | PMC7349026 | |
dc.identifier.pmid | 32570971 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/3877 | |
dc.journal.title | Cells | |
dc.language.iso | en | |
dc.page.number | 17 p. | |
dc.publisher | MDPI | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2073-4409/9/6/1492/htm | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.accessRights | Acceso abierto | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Models | es_ES |
dc.subject | DNA donor | es_ES |
dc.subject | On-target integration | es_ES |
dc.subject | Homologous directed recombination (HDR) | es_ES |
dc.subject | Efficacy | es_ES |
dc.subject | Safety | es_ES |
dc.subject | Specificity | es_ES |
dc.subject | eGFP | es_ES |
dc.subject | dsRED | es_ES |
dc.subject | CRISPR/Cas9 | es_ES |
dc.subject | Modelos estructurales | es_ES |
dc.subject | Reparación del ADN por recombinación | es_ES |
dc.subject | Eficacia | es_ES |
dc.subject | Seguridad | es_ES |
dc.subject | Especificidad | es_ES |
dc.subject | Proteínas fluorescentes verdes | es_ES |
dc.subject | Proteína 9 asociada a CRISPR | es_ES |
dc.subject | ADN recombinante | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::DNA::DNA, Recombinant | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Targeting | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, Reporter | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Genetic Engineering | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Genetic Therapy | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genetic Vectors | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor::K562 Cells | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Macromolecular Substances::Polymers::Biopolymers::Microfilament Proteins::Wiskott-Aldrich Syndrome Protein Family::Wiskott-Aldrich Syndrome Protein | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Epigenesis, Genetic::Gene Silencing::CRISPR-Cas Systems | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Recombination, Genetic::Homologous Recombination | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Biological::Models, Genetic | es_ES |
dc.title | Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System | es_ES |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- SanchezHernandez_DevelopmentOf.pdf
- Size:
- 2.35 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo original
Loading...
- Name:
- SanchezHernandez_DevelopmentOf_MaterialSuplementario.pdf
- Size:
- 551.19 KB
- Format:
- Adobe Portable Document Format
- Description:
- Material suplementario